Teva Prepares To Launch LAI Risperidone After US Approval :: Generics Bulletin
FDA warns of Adderall shortage after Teva manufacturing delay - YouTube
Teva wins FDA nod for once-daily Austedo (NYSE:TEVA) | Seeking Alpha
Teva Announces FDA Approval of First and Only Digital Inhaler with Built-In Sensors – ProAir® Digihaler™ | SnackSafely.com
Teva Pharmaceutical: Shares rise after FDA approves new migraine drug | Business News - The Indian Express
Teva Pharmaceuticals gets FDA approval for Osteoporosis injection | Eric A. Hughes, MD, PhD posted on the topic | LinkedIn
Regeneron and Teva's fasinumab hit with FDA clinical hold | Fierce Biotech
Teva Pharmaceuticals USA, Inc., Issues Voluntary Nationwide Recall of Specific Lots of Fentanyl Buccal Tablets CII Because of Labeling Error | ONS Voice
Teva Wins FDA Approval for Digital Inhaler Combining Powder with Sensors, App
FDA: Teva antidepressant is ineffective
Teva Pharmaceuticals USA Issues Voluntary Nationwide Recall of all Amlodipine/Valsartan Combination Tablets and Amlodipine/Valsartan/Hydrochlorothiazide Combination Tablets that are Within Expiry | FDA
Pharma News | Bristol Myers Squibb, Teva, MedinCell, Biogen
FDA News Roundup Teva AstraZeneca Amgen Medicines Company And More
FDA Roundup AstraZeneca Teva Amgen And More
Jury finds Teva Pharmaceuticals fueled opioid epidemic in New York State
Teva, MedinCell receive FDA approval for Uzedy for schizophrenia
Teva Issues Voluntary Nationwide Recall of One Lot of Anagrelide Capsules | DAIC
FDA Confirms Nationwide Adderall Shortage After Weeks of Reported Backlogs
Teva refiles long-acting schizophrenia drug after FDA rejection
Joshua Russell on LinkedIn: Teva temporarily padlocks a plant after FDA cites it for contamination
Teva and MedinCell Announce FDA Approval of UZEDY™ (risperidone) Extended-Release Injectable Suspension, a Long-Acting Subcutaneous Atypical Antipsychotic Injection, for the Treatment of Schizophrenia in Adults | Business Wire
Teva Earns First FDA Approval for Generic Drug for Major Depressive Disorder | 2019-10-10 | FDAnews
Mylan's fight against Teva highlights logjam created by FDA petitions | Modern Healthcare
Teva Announces Approval of a Generic Version of Forteo® (teriparatide injection), in the U.S.
Good news for Teva as FDA expedites novel-class migraine therapy
FDA approves Teva's generic EpiPen after yearslong delay
